The store will not work correctly when cookies are disabled.
3-(2-Methoxyphenyl)-4-((3-(methylsulfonyl)phenyhamino)-1H-pyrrole-2,5-dione
ID: ALA4877795
PubChem CID: 164629183
Max Phase: Preclinical
Molecular Formula: C18H16N2O5S
Molecular Weight: 372.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccccc1C1=C(Nc2cccc(S(C)(=O)=O)c2)C(=O)NC1=O
Standard InChI: InChI=1S/C18H16N2O5S/c1-25-14-9-4-3-8-13(14)15-16(18(22)20-17(15)21)19-11-6-5-7-12(10-11)26(2,23)24/h3-10H,1-2H3,(H2,19,20,21,22)
Standard InChI Key: LBJAKOPDRBCRJD-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
6.8058 -32.0768 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8099 -31.2596 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.1002 -31.6647 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0737 -29.1868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8909 -29.1868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1453 -28.4101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4823 -27.9280 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8236 -28.4101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6493 -29.8851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8300 -29.8652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4049 -30.5638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7981 -31.2826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6206 -31.2986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0419 -30.5994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3705 -29.8485 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1838 -29.8481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5889 -30.5546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4015 -30.5545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8086 -29.8495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3973 -29.1430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5861 -29.1465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9228 -28.1587 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0463 -28.1579 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4382 -29.1481 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6273 -31.2623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6134 -29.1286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 1 0
7 8 1 0
8 4 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
9 4 1 0
5 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
6 22 2 0
8 23 2 0
10 24 1 0
18 2 1 0
2 25 1 0
24 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 372.40 | Molecular Weight (Monoisotopic): 372.0780 | AlogP: 1.58 | #Rotatable Bonds: 5 |
Polar Surface Area: 101.57 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.56 | CX Basic pKa: ┄ | CX LogP: 0.63 | CX LogD: 0.63 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.77 | Np Likeness Score: -0.76 |
References
1. Serafim RAM, Sorrell FJ, Berger BT, Collins RJ, Vasconcelos SNS, Massirer KB, Knapp S, Bennett J, Fedorov O, Patel H, Zuercher WJ, Elkins JM.. (2021) Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold., 64 (18.0): [PMID:34463505] [10.1021/acs.jmedchem.0c01579] |